ICYMI: Successful Phase 3 Study of Familial Chylomicronemia Syndrome Drug May Win Drug Approval in US
<a href="https://pixabay.com/users/TeroVesalainen/">TeroVesalainen</a> / Pixabay

ICYMI: Successful Phase 3 Study of Familial Chylomicronemia Syndrome Drug May Win Drug Approval in US

According to a publication from BioPortfolio, American biotechnology companies Akcea Therapeutics and Ionis Pharmaceuticals recently published final study results from their phase 3 clinical study of Waylivra (generic name volanesorsen)…

Continue Reading
Global Genes Highlights Firefighter Experience with Familial Chylomicronemia Syndrome
<a href="https://pixabay.com/users/felljagd3150/">felljagd3150</a> / Pixabay

Global Genes Highlights Firefighter Experience with Familial Chylomicronemia Syndrome

Severe diarrhea. Daily abdominal pain. Extremely high triglycerides. Chronic pancreatitis. Joint pain. Incredibly uncomfortable conditions for anyone. Now imagine you’ve experienced this pain your entire life without knowing what was…

Continue Reading
Close Menu